Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What's the Difference?

Avci, AB; Feist, E; Burmester, GR

Feist, E (reprint author), Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany.

BIODRUGS, 2018; 32 (6): 531

Abstract

Interleukin-6 (IL-6) signaling is a critical target in inflammatory pathways. Today, tocilizumab (TCZ) and sarilumab (SAR), two IL-6 receptor-inhibiti......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索